Differential immunohistochemical localization of desmosomal plaque-related proteins in non-small-cell lung cancer

Histopathology

Volumn 63, Issue 1, 2013, Pages 103-113

  Gómez Morales, Mercedes ^a   Cámara Pulido, Miguel ^a   Miranda León, María Teresa ^a   Sánchez Palencia, Abel ^b   Boyero, Laura ^a   Gómez Capilla, José Antonio ^a   Fárez Vidal, María Esther ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Adenocarcinoma; Desmosomal plaque proteins; Non small cell lung cancer; Squamous cell carcinoma

Indexed keywords

CYTOKERATIN 15; DESMOGLEIN 3; PLAKOPHILIN; PLAKOPHILIN 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER TISSUE; CONTROLLED STUDY; DESMOSOME; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENSITIVITY AND SPECIFICITY;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; DESMOGLEIN 3; DESMOSOMES; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-15; LUNG NEOPLASMS; PLAKOPHILINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84879461017     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12126     Document Type: Article

References (52)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics 2009. CA Cancer J. Clin. 2009; 59; 225-249.
2. Travis D, Brambilla E, Müller-Hermelink HK, Harris CC. WHO classification. Tumors of the lung, pleura, thymus and heart. Albany, NY: WHO Publication Center, 2004.
3. Hirsch FR, Spreafico A, Novello S, Wood MD, Simms L, Papotti M. The prognostic and predictive role of histology in advanced nonsmall cell lung cancer: a literature review. J. Torca. Oncol. 2008; 3; 1468-1481.
4. Scagliotti GV, Parikh P, von Pawel J et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus permetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J. Clin. Oncol. 2008; 26; 3543-3551.
5. Azzoli CG, Baker S Jr, Temin S et al. American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer. J. Clin. Oncol. 2009; 26; 6251-6266.
6. Rosell R, Moran T, Queralt C et al. Spanish Lung Cancer Group. Screening for epidermal growth factor receptor mutations in lung cancer. N. Engl. J. Med. 2009; 361; 958-967.
7. Kwak EL, Bang YJ, Camidge DR et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N. Engl. J. Med. 2010; 363; 1693-1703.
8. Sterlacci W, Savic S, Schmid T et al. Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact. Am. J. Clin. Pathol. 2012; 137; 946-956.
9. Travis WD, Brambilla E, Noguchi M et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J. Thorac. Oncol. 2011; 6; 244-285.
10. Mukhopadhyay S, Katzenstein AL. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, CK5/6. Am. J. Surg. Pathol. 2011; 35; 15-25.
11. Kargi A, Gurel D, Tuna B. The diagnostic value of TTF-1, CK5-6, and p63 immunostaining in classification of lung carcinomas. Appl. Immunohistochem. Mol. Morphol. 2007; 15; 415-420.
12. Bishop JA, Teruya-Feldstein J, Westra WH, Pelosi G, Travis WD, Rekhtman N. p40 ({increment}Np63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod. Pathol. 2012; 25; 405-415.
13. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am. J. Physiol. 2004; 286; C1213-C1228.
14. Nagafuchi A. Molecular architecture of adherens junctions. Curr. Opin. Cell Biol. 2001; 13; 600-603.
15. Evans WH, Martin PE. Gap junctions: structure and function. Mol. Membr. Biol. 2002; 19; 121-136.
16. Yin T, Green KJ. Regulation of desmosome assembly and adhesion. Semin. Cell Dev. Biol. 2004; 15; 665-677.
17. Borrmann CM, Mertens C, Schmidt A, Langbein L, Kuhn C, Franke WW. Molecular diversity of plaques of epithelial-adhering junctions. Ann. NY Acad. Sci. 2000; 915; 144-150.
18. Schmidt A, Jäger S. Plakophilins - hard work in the desmosome, recreation in the nucleus? Eur. J. Cell Biol. 2005; 84; 189-204.
19. Hatzfel M. Plakophilins: multifunctional proteins or just regulators of desmosomal adhesion? Biochim. Biophys. Acta 2007; 1773; 69-77.
20. Bass-Zubek AE, Godsel LM, Delmar M, Green KJ. Plakophilins: multifunctional scaffolds for adhesion and signaling. Curr. Opin. Cell Biol. 2009; 21; 708-716.
21. Koch PJ, Goldschmidt MD, Walsh MJ, Zimbelmann R, Franke WW. Complete amino acid sequence of the epidermal desmoglein precursor polypeptide and identification of a second type of desmoglein gene. Eur. J. Cell Biol. 1991; 55; 200-208.
22. Joo YE, Rew JS, Choi SK, Bom HS, Park CS, Kim SJ. Expression of E-cadherin and catenins in early gastric cancer. J. Clin. Gastroenterol. 2002; 35; 35-42.
23. Nakamura E, Sugihara H, Bamba M, Hattori T. Dynamic alteration of the E-cadherin/catenin complex during cell diferentiation and invasion of undifferentiated-type gastric carcinomas. J. Pathol. 2005; 205; 349-358.
24. Schwarz J, Ayim A, Schmidt A et al. Differential expression of desmosomal plakophilins in various types of carcinomas: correlation with cell type and differentiation. Hum. Pathol. 2006; 37; 613-622.
25. Sanchez-Palencia A, Gomez-Morales M, Gomez-Capilla JA et al. Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer. Int. J. Cancer 2010; 129; 355-364.
26. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111; 1710-1717.
27. Chidgey M, Dawson C. Desmosomes: a role in cancer? Br. J. Cancer 2007; 96; 1783-1787.
28. Demirag GG, Sullu Y, Gurgenyatagi D, Okumus NO, Yucel I. Expression of plakophilins (PKP1, PKP2 and PKP3) in gastric cancers. Diagn. Pathol. 2011; 6; 1-5.
29. Neuber S, Mühmer M, Wratten D, Koch PJ, Moll R, Schmidt A. The desmosomal plaque proteins of the plakophilin family. Dermatol. Res. Pract. 2010; 2010; 101452.
30. Moll I, Kurzen H, Langbein L, Franke WW. The distribution of the desmosomal protein, plakophilin 1, in human skin and skin tumors. J. Invest. Dermatol. 1997; 108; 139-46.
31. Mertens C, Kuhn C, Moll R, Schwetlick I, Franke WW. Desmosomal plakophilin 2 as a differentiation marker in normal and malignant tissues. Differentiation 1999; 64; 277-290.
32. Villaret DB, Wang T, Dillon D et al. Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 2000; 110; 374-381.
33. Papagerakis S, Shabana AH, Depondt J, Gehanno P, Forest N. Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, and p0071) in primary oropharyngeal tumors: correlation with clinical parameters. Hum. Pathol. 2003; 34; 565-572.
34. Furukawa C, Daigo Y, Ishikawa N et al. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res. 2005; 65; 7102-7110.
35. Fukuoka J, Dracheva T, Shih JH et al. Desmoglein 3 as a prognostic factor in lung cancer. Hum. Pathol. 2007; 38; 276-283.
36. Tacha D, Yu C, Bremer R, Qi W, Haas T. A 6-antibody panel for the classification of lung adenocarcinoma versus squamous cell carcinoma. Appl. Immunohistochem. Mol. Morphol. 2012; 20; 201-207.
37. Agackiran Y, Ozcan A, Akyurek N, Memis L, Findik G, Kaya S. Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes. Appl. Immunohistochem. Mol. Morphol. 2012; 20; 350-355.
38. Mertens C, Kuhn C, Franke WW. Plakophilins 2a and 2b: constitutive proteins of dual location in the karyoplasm and the desmosomal plaque. J. Cell Biol. 1996; 4; 1009-1025.
39. Schmidt A, Langbein L, Pratzel S, Rode M, Rackwitz HR, Franke WW. Plakophilin 3 - a novel cell-type-specific desmosomal plaque protein. Differentiation 1999; 5; 291-306.
40. Schmidt A, Langbein L, Rode M, Prätzel S, Zimbelmann R, Franke WW. Plakophilins 1a and 1b: widespread nuclear proteins recruited in specific epithelial cells as desmosomal plaque components. Cell Tissue Res. 1997; 290; 481-499.
41. Hatzfeld M, Haffner C, Schulze K, Vinzens U. The function of plakophilin 1 in desmosome assembly and actin filament organization. J. Cell Biol. 2000; 149; 209-222.
42. Sobolik-Delmaire T, Katafiasz D, Keim SA, Mahoney MG, Wahl JK III. Decreased plakophilin-1 expression promotes increased motility in head and neck squamous cell carcinoma cells. Cell. Commun. Adhes. 2007; 14; 99-109.
43. Sobolik-Delmaire T, Roopa R, Pashaj A, Roberts BJ, Wahl JK. Plakophilin-1 localizes to the nucleus and interacts with single-stranded DNA. J. Invest. Dermatol. 2010; 130; 2638-2646.
44. Nuber UA, Schäfer S, Stehr S, Rackwitz HR, Franke WW. Patterns of desmocollin synthesis in human epithelia: immunolocalization of desmocollins 1 and 3 in special epithelia and in cultured cells. Eur. J. Cell Biol. 1996; 71; 1-13.
45. Nuber UA, Schäfer S, Schmidt A, Koch PJ, Franke WW. The widespread human desmocollin Dsc2 and tissue-specific patterns of synthesis of various desmocollin subtypes. Eur. J. Cell Biol. 1995; 66; 69-74.
46. Schäfer S, Nuber UA, Moll R. Desmosomes and hemidesmosomes: differences and similarities in skin and mucosae. In Pleyer U, Hartmann C, Sterry W eds. Oculodermal diseases. Buren: Aeolus Press, 1997; 75-94.
47. Travis WD, Brambilla E, Noguchi M et al. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch. Pathol. Lab. Med. 2012; 136; 1-17.
48. Pelosi G, Fabbri A, Bianchi F et al. ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach. J. Thorac. Oncol. 2012; 7; 281-290.
49. Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. Mod. Pathol. 2011; 24; 1348-1359.
50. Boelens MC, van den Berg A, Vogelzang I et al. Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus. J. Clin. Pathol. 2007; 60; 608-614.
51. Cowin P, Kapprell HP, Franke WW, Tamkun J, Hynes RO. Plakoglobin: a protein common to different kinds of intercellular adhering junctions. Cell 1986; 46; 1063-1073.
52. Breuninger S, Reidenbach S, Sauer CG et al. Desmosomal plakophilins in the prostate and prostatic adenocarcinomas: implications for diagnosis and tumor progression. Am. J. Pathol. 2010; 176; 2509-2519.